Sep 06,2017

One Drop Launches Power of 10 Program to Provide Free Ada-Recognized Diabetes Education and Support To Those Most in Need

One Drop today announced the Power of 10, a charitable giving program where, for every One Drop subscription sold, One Drop is donating 10 subscriptions to One Drop | Experts, its ADA-Recognized digital diabetes support and education program, to medically underserved and uninsured people with diabetes.

View Analyst & Ambassador Comments
Go to original news
Sep 06,2017

J. Bradley Wilson Appointed to the Fit4D (now named Cecelia Health) Board of Directors

Fit4D (now named Cecelia Health), a New York City-based healthcare services company, announced today that J. Bradley (Brad) Wilson will join its Board of Directors.

View Analyst & Ambassador Comments
Go to original news
Sep 07,2017

DarioHealth Launches Its Dario App in the Google Play Store Expanding Its U.S. Market Reach

DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, today announced the launch of its Dario app for certain leading Android smart mobile devices (SMD) in the U.S. The company's Dario Blood Glucose Monitoring System (BGMS) is now available and ready to ship its to Android users in the U.S.

PRODUCT

#mobile app

View Analyst & Ambassador Comments
Go to original news
Sep 08,2017

One Drop Premium on iPhone and Apple Watch Lowers A1c by 1.2% in 3 Months

One Drop will present real-world data from an evaluation of One Drop | Experts with the Apple Watch at the Stanford Medicine X Conference next week. Using retrospective app-collected data, the company will report peer-reviewed drastic improvements in self-care and blood glucose among people with type 2 diabetes (T2D). Specifically, people with type 2 diabetes and A1c levels equal to or greater than 7.5% who used the One Drop | Mobile app with One Drop | Experts (now called One Drop Premium) on iPhone and Apple Watch for three months saw a 1.2% absolute reduction in A1C.

CLINICAL STUDY

#mobile app

View Analyst & Ambassador Comments
Go to original news
Sep 11,2017

A new way to provide care in everyday routines: Roche Diabetes Care integrates diabetes management solutions in an open ecosystem for more time in range

Roche Diabetes Care drives an open ecosystem approach with integrated diabetes management solutions to support improved therapy outcomes and to help achieve more time in range. The ecosystem will not only integrate physical products like blood glucose meters, continuous glucose monitoring systems, connected insulin pens or pumps but also digitally enabled coaching and prescription services.

PRODUCT
View Analyst & Ambassador Comments
Go to original news
Sep 11,2017

Brighter draws down the second tranche under the financing agreement with L1 Capital and issues additional free warrants to its shareholders

Brighter has called upon a second Tranche of SEK 10 million in line with the terms from the financing agreement communicated on the 26thof April 2017. The transaction is carried out through a private placement of convertible notes with warrants attached.

View Analyst & Ambassador Comments
Go to original news
Sep 12,2017

Ascensia Diabetes Care and Quattro Folia Announce Technology Collaboration to Support More Effortless Insulin Management for Patients

Ascensia Diabetes Care and Quattro Folia today announced a technology partnership that connects the CONTOUR®NEXT ONE blood glucose monitoring system (BGMS) from Ascensia to Quattro Folia’s Balansio Mobile app. By enabling the effortless transfer of highly accurate blood glucose values for insulin calculations, this collaboration aims to optimize insulin management for patients.

COLLABORATION PARTNERSHIP

#connected device

#bgm

#mobile app

View Analyst & Ambassador Comments
Go to original news
Sep 12,2017

Senseonics Announces CE Mark Approval for Eversense® XL CGM System

Senseonics Holdings, Inc. (NYSE-MKT-SENS) today announced it has received CE Mark approval for the Eversense® XL Continuous Glucose Monitoring (CGM) System. The Eversense XL System includes an extended life implanted glucose sensor lasting up to 180 days, a removable discreet smart transmitter, and a mobile app for display of real-time glucose readings.

REGULATORY CE MARK
View Analyst & Ambassador Comments
Go to original news
Sep 13,2017

Ascensia Diabetes Care Launches Global Innovation Competition to Find Digital Solutions to Help Tackle the Epidemic of Type 2 Diabetes

Today, during the 53rd Annual Meeting of the European Association for the Study of Diabetes (EASD), Ascensia Diabetes Care announced the launch of the Ascensia Diabetes Challenge, a global innovation competition that is seeking innovative digital solutions to support diabetes management and improve the lives of those living with type 2 diabetes.

View Analyst & Ambassador Comments
Go to original news
Sep 13,2017

Insulet Corporation Presents Real-World Clinical Data on the Use of Its Omnipod® Insulin Management System in Approximately 39,000 Patients Using a Cloud-Based Data Management System

Insulet Corporation (NASDAQ:PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod System), today presented real-world clinical data at the Congress of the European Association for the Study of Diabetes (EASD) in Lisbon, Portugal. The data are from a study of 38,778 patients in the United States with type 1 and type 2 diabetes who received insulin using the Omnipod System with at least three months of data downloaded using Insulet Provided Glooko (a cloud-based diabetes data management system). The data demonstrated this use was associated with frequent fingerstick blood glucose testing through the integrated Abbott FreeStyle® glucose meter and high usage of the advanced features of the Omnipod System.

CLINICAL STUDY

#insulin pump

View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES